512 Shincheonji Members Donated Recovered COVID-19 Blood Plasma

512 Shincheonji Members Donated Recovered COVID-19 Blood Plasma

  Amid the continuous spread of the novel coronavirus infectious disease (COVID-19) around the world, expectations are growing for the development of the treatment as news of the start of the production of COVID-19 medicine for clinical trials in South Korea.

 

  According to GC Green Cross on the 20th, products for clinical trials of "GC5131A," a COVID-19 blood plasma medicine, have begun to be produced. The production is taking place in Cheongju, Korea. The study on blood treatment is being conducted jointly by GC Green Cross with the National Institutes of Health.

 

  GC5131A is a drug developed from the extraction of various antibodies contained in the plasma of recovered patients of COVID-19. Based on the judgment that the safety of the human body has been secured, phase 1 of the clinical trial was exempted, and it will start from phase 2.

 

  Meanwhile, a total of 1,032 people expressed their intention to donate plasma, the GC Green Cross said. Among them, 642 people were reported to have blood plasma collection.

 

  In addition to clinical administration, GC5131A is expected to be used at medical sites for a variety of purposes, including the use of therapeutic purposes.

 

  Kim Jin, head of the GC Green Cross Medical Division, said, "The blood plasma agent is a treatment that is made by lots of the people," adding, "We will do our best to make it available at the medical field in the near future."

 

  Blood treatment agents are made by enriching and sanctioning small amounts of antibodies and immunoglobulins contained in the blood of a complete healer. This requires a lot of blood. However, due to the lack of plasma donors and the need to be suitable for blood collection, GC Green Cross had difficulty developing treatments.

 

  Among the situation, more than 4,000 Shincheonji congregation expressed their intention to donate plasma on the 23rd of June, raising expectations for the development of COVID-19 treatment. On July, a group plasma donation was completed by Shincheonji believers who were confirmed to have been diagnosed with COVID-19.

  "A total of 546 members of the Shincheonji Daegu Church participated group plasma donation from the 13th to the 17th, and 409 people completed the plasma donation, except for 137 unconformable people," said a official of Shincheonji Daegu Church.

 

  Apart from the group plasma donation, 103 Shincheonji members individually donated plasma at Keimyung University Dongsan Hospital.

 

  Meanwhile, Son Yeong-jin (false name, 23, Male), a Shincheonji believer who participated as a plasma donor, said, "I was a little nervous, but I was encouraged to participate because I thought that this plasma donation could help many people suffering from COVID-19."

 

The reference article : http://reurl.kr/2CF91C0FIK

#CoronavirusOutbreak #ShincheonjiChurch #StopFakeNews #CoronaVirus #ShincheonjiPress #FakeNews #FactCheck